On high-frequency insulin oscillations

Ageing Research Reviews

Volumn 7, Issue 4, 2008, Pages 301-305

  Schmitz, Ole ^a   Rungby, Joergen ^a   Edge, Linda ^a   Juhl, Claus B ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Department of Software Engineering and Media Technology   (Denmark)

Author keywords

Hypoglycemic agents; Insulin action; Insulin pulsatility; Prediabetes; Type 2 diabetes

Indexed keywords

EXENDIN; GLICLAZIDE; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOSE; INCRETIN; INSULIN; LIRAGLUTIDE; PIOGLITAZONE; POTASSIUM CHANNEL STIMULATING AGENT; REPAGLINIDE; ROSIGLITAZONE; SOMATOSTATIN; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE; UNCLASSIFIED DRUG;

ACUTE DRUG ADMINISTRATION; CELL COMMUNICATION; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PULSATILE HORMONE RELEASE; SHORT SURVEY; SINGLE DRUG DOSE; ULTRADIAN RHYTHM;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; PERIODICITY;

SUS;

EID: 53049086822     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2008.04.002     Document Type: Short Survey

References (42)

1. Bergsten P. Pathophysiology of impaired pulsatile insulin release. Diabetes Metab. Res. Rev. 16 (2000) 179-191
2. Bingley P.J., Matthews D.R., Williams A.J., Bottazzo G.F., and Gale E.A. Loss of regular oscillatory insulin secretion in islet cell antibody positive non-diabetic subjects. Diabetologia 35 (1992) 32-38
3. Bratusch-Marrain P.R., Komjati M., and Waldhausl W.K. Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans. Diabetes 35 (1986) 922-926
4. Finegood D.T., McArthur M.D., Kojwang D., Thomas M.J., Topp B.G., Leonard T., and Buckingham R.E. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 50 (2001) 1021-1029
5. Goodner C.J., Walike B.C., Koerker D.J., Ensinck J.W., Brown A.C., Chideckel E.W., Palmer J., and Kalnasy L. Insulin, glucagon, and glucose exhibit synchronous, sustained oscillations in fasting monkeys. Science 195 (1977) 177-179
6. Hansen B.C., Jen K.C., Belbez P.S., and Wolfe R.A. Rapid oscillations in plasma insulin, glucagon, and glucose in obese and normal weight humans. J. Clin. Endocrinol. Metab. 54 (1982) 785-792
7. Hollingdal M., Juhl C.B., Pincus S.M., Sturis J., Veldhuis J.D., Polonsky K.S., Porksen N., and Schmitz O. Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes. Diabetes 49 (2000) 1334-1340
8. Hollingdal M., Sturis J., Gall M.A., Damsbo P., Pincus S., Veldhuis J.D., Porksen N., Schmitz O., and Juhl C.B. Repaglinide treatment amplifies first-phase insulin secretion and high-frequency pulsatile insulin release in Type 2 diabetes. Diabet. Med. 22 (2005) 1408-1413
9. Juhl C.B., Hollingdal M., Porksen N., Prange A., Lonnqvist F., and Schmitz O. Influence of rosiglitazone treatment on beta-cell function in type 2 diabetes: evidence of an increased ability of glucose to entrain high-frequency insulin pulsatility. J. Clin. Endocrinol. Metab. 88 (2003) 3794-3800
10. Juhl C.B., Porksen N., Pincus S.M., Hansen A.P., Veldhuis J.D., and Schmitz O. Acute and short-term administration of a sulfonylurea (gliclazide) increases pulsatile insulin secretion in type 2 diabetes. Diabetes 50 (2001) 1778-1784
11. Juhl C.B., Sturis J., Hollingdal M., and Schmitz O. Acute insulin responses to intravenous glucose and GLP-1 are independent of preceding high-frequency insulin pulse-defects induced by glucose entrainment in healthy humans. Horm. Metab. Res. 37 (2005) 40-44
12. Kjems L.L., Kirby B.M., Welsh E.M., Veldhuis J.D., Straume M., McIntyre S.S., Yang D., Lefebvre P., and Butler P.C. Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes 50 (2001) 2001-2012
13. Laedtke T., Kjems L., Porksen N., Schmitz O., Veldhuis J., Kao P.C., and Butler P.C. Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E520-E528
14. Lang D.A., Matthews D.R., Burnett M., and Turner R.C. Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man. Diabetes 30 (1981) 435-439
15. Lang D.A., Matthews D.R., Burnett M., Ward G.M., and Turner R.C. Pulsatile, synchronous basal insulin and glucagon secretion in man. Diabetes 31 (1982) 22-26
16. Larsen M.O., Gotfredsen C.F., Wilken M., Carr R.D., Porksen N., and Rolin B. Loss of beta-cell mass leads to a reduction of pulse mass with normal periodicity, regularity and entrainment of pulsatile insulin secretion in Gottingen minipigs. Diabetologia 46 (2003) 195-202
17. Leahy J.L. Natural history of beta-cell dysfunction in NIDDM. Diabetes Care 13 (1990) 992-1010
18. Lefebvre P.J., Paolisso G., Scheen A.J., and Henquin J.C. Pulsatility of insulin and glucagon release: physiological significance and pharmacological implications. Diabetologia 30 (1987) 443-452
19. Matthews D.R., Naylor B.A., Jones R.G., Ward G.M., and Turner R.C. Pulsatile insulin has greater hypoglycemic effect than continuous delivery. Diabetes 32 (1983) 617-621
20. Meier J.J., Gethmann A., Nauck M.A., Gotze O., Schmitz F., Deacon C.F., Gallwitz B., Schmidt W.E., and Holst J.J. The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E1118-E1123
21. Meneilly G.S., Ryan A.S., Veldhuis J.D., and Elahi D. Increased disorderliness of basal insulin release, attenuated insulin secretory burst mass, and reduced ultradian rhythmicity of insulin secretion in older individuals. J. Clin. Endocrinol. Metab. 82 (1997) 4088-4093
22. O'Rahilly S., Turner R.C., and Matthews D.R. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N. Engl. J. Med. 318 (1988) 1225-1230
23. Paolisso G., Sgambato S., Gentile S., Memoli P., Giugliano D., Varricchio M., and D'Onofrio F. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients. J. Clin. Endocrinol. Metab. 67 (1988) 1005-1010
24. Peiris A.N., Stagner J.I., Vogel R.L., Nakagawa A., and Samols E. Body fat distribution and peripheral insulin sensitivity in healthy men: role of insulin pulsatility. J. Clin. Endocrinol. Metab. 75 (1992) 290-294
25. Polonsky K.S., Given B.D., Hirsch L.J., Tillil H., Shapiro E.T., Beebe C., Frank B.H., Galloway J.A., and Van C.E. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 318 (1988) 1231-1239
26. Polonsky K.S., Sturis J., and Bell G.I. Seminars in Medicine of the Beth Israel Hospital. Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. N. Engl. J. Med. 334 (1996) 777-783
27. Porksen N., Grofte T., Greisen J., Mengel A., Juhl C., Veldhuis J.D., Schmitz O., Rossle M., and Vilstrup H. Human insulin release processes measured by intraportal sampling. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E695-E702
28. Porksen N., Hollingdal M., Juhl C., Butler P., Veldhuis J.D., and Schmitz O. Pulsatile insulin secretion: detection, regulation, and role in diabetes. Diabetes 51 Suppl. 1 (2002) S245-S254
29. Porksen N., Juhl C., Hollingdal M., Pincus S.M., Sturis J., Veldhuis J.D., and Schmitz O. Concordant induction of rapid in vivo pulsatile insulin secretion by recurrent punctuated glucose infusions. Am. J. Physiol. Endocrinol. Metab. 278 (2000) E162-E170
30. Porksen N., Nyholm B., Veldhuis J.D., Butler P.C., and Schmitz O. In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts. Am. J. Physiol. 273 (1997) E908-E914
31. Porksen N.K., Munn S.R., Steers J.L., Schmitz O., Veldhuis J.D., and Butler P.C. Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: selective amplification of insulin secretory burst mass. Diabetes 45 (1996) 1792-1797
32. Ristow M., Carlqvist H., Hebinck J., Vorgerd M., Krone W., Pfeiffer A., Muller-Wieland D., and Ostenson C.G. Deficiency of phosphofructo-1-kinase/muscle subtype in humans is associated with impairment of insulin secretory oscillations. Diabetes 48 (1999) 1557-1561
33. Ritzel R., Schulte M., Porksen N., Nauck M.S., Holst J.J., Juhl C., Marz W., Schmitz O., Schmiegel W.H., and Nauck M.A. Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance. Diabetes 50 (2001) 776-784
34. Schmitz O., Arnfred J., Nielsen O.H., Beck-Nielsen H., and Orskov H. Glucose uptake and pulsatile insulin infusion: euglycaemic clamp and [3-3H]glucose studies in healthy subjects. Acta Endocrinol. (Copenh.) 113 (1986) 559-563
35. Schmitz O., Juhl C.B., Hollingdal M., Veldhuis J.D., Porksen N., and Pincus S.M. Irregular circulating insulin concentrations in type 2 diabetes mellitus: an inverse relationship between circulating free fatty acid and the disorderliness of an insulin time series in diabetic and healthy individuals. Metabolism 50 (2001) 41-46
36. Schmitz O., Pedersen S.B., Mengel A., Porksen N., Bak J., Moller N., Richelsen B., Alberti K.G., Butler P.C., and Orskov H. Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjects. Metabolism 43 (1994) 842-846
37. Schmitz O., Porksen N., Nyholm B., Skjaerbaek C., Butler P.C., Veldhuis J.D., and Pincus S.M. Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM. Am. J. Physiol. 272 (1997) E218-E226
38. Stagner J.I., and Samols E. Role of intrapancreatic ganglia in regulation of periodic insular secretions. Am. J. Physiol. 248 (1985) E522-E530
39. Sturis J., O'Meara N.M., Shapiro E.T., Blackman J.D., Tillil H., Polonsky K.S., and Van C.E. Differential effects of glucose stimulation upon rapid pulses and ultradian oscillations of insulin secretion. J. Clin. Endocrinol. Metab. 76 (1993) 895-901
40. Sturis J., Pugh W.L., Tang J., and Polonsky K.S. Prevention of diabetes does not completely prevent insulin secretory defects in the ZDF rat. Am. J. Physiol. 269 (1995) E786-E792
41. Tornheim K. Are metabolic oscillations responsible for normal oscillatory insulin secretion?. Diabetes 46 (1997) 1375-1380
42. Weigle D.S. Pulsatile secretion of fuel-regulatory hormones. Diabetes 36 (1987) 764-775